Torelli P, Jensen RH, Tavanaiepour D, et al. The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 2013; 53: 137-146.
Blumenfeld AM, Bloudek LM, Becker WJ, et al. Patterns of use and reasons for discontinuation of prophylactic medications for episodic migraine and chronic migraine: Results from the second International Burden of Migraine Study (IBMS-II). Headache 2013; 53: 644-655.
Magis D,. Neuromodulation in migraine: State of the art and perspectives. Expert Rev Med Devices 2015; 12: 329-339.
Schoenen J, Vandersmissen B, Jeangette S, et al. Migraine prevention with a supraorbital transcutaneous stimulator: A randomized controlled trial. Neurology 2013; 80: 697-704.
Russo A, Tessitore A, Conte F, et al. Transcutaneous supraorbital neurostimulation in "de novo" patients with migraine without aura: The first Italian experience. J Headache Pain 2015; 16: 69-69.
Magis D, Sava S, D'Elia TS, et al. Safety and patients' satisfaction of transcutaneous supraorbital neurostimulation (tSNS) with the Cefaly® device in headache treatment: A survey of 2,313 headache sufferers in the general population. J Headache Pain 2013; 14: 95-95.
Willoch F, Gamringer U, Medele R, et al. Analgesia by electrostimulation of the trigeminal ganglion in patients with trigeminopathic pain: A PET activation study. Pain 2003; 103: 119-130.
Magis D, Bruno MA, Fumal A, et al. Central modulation in cluster headache patients treated with occipital nerve stimulation: An FDG-PET study. BMC Neurol 2011; 11: 25-25.
Matharu MS, Bartsch T, Ward N, et al. Central neuromodulation in chronic migraine patients with suboccipital stimulators: A PET study. Brain 2004; 127: 220-230.
Kovacs S, Peeters R, De Ridder D, et al. Central effects of occipital nerve electrical stimulation studied by functional magnetic resonance imaging. Neuromodulation 2011; 14: 46-47.
Streel S, Donneau AF, Dardenne N, et al. Validation of an extended French version of ID Migraine as a migraine-screening tool. Cephalalgia 2015; 35: 437-442.
Petrovic P, Kalso E, Petersson KM, et al. Placebo and opioid analgesia-imaging a shared neuronal network. Science 2002; 295: 1737-1740.
Fumal A, Laureys S, Di Clemente L, et al. Orbitofrontal cortex involvement in chronic analgesic-overuse headache evolving from episodic migraine. Brain 2006; 129: 543-550.
Riederer F, Gantenbein AR, Marti M, et al. Decrease of gray matter volume in the midbrain is associated with treatment response in medication-overuse headache: Possible influence of orbitofrontal cortex. J Neurosci 2013; 33: 15343-15349.
Ferraro S, Grazzi L, Mandelli ML, et al. Pain processing in medication overuse headache: A functional magnetic resonance imaging (fMRI) study. Pain Med 2012; 13: 255-262.
Sprenger T, Borsook D,. Migraine changes the brain: Neuroimaging makes its mark. 2012; 25: 252-262.
Maniyar FH, Sprenger T, Monteith T, et al. Brain activations in the premonitory phase of nitroglycerin-triggered migraine attacks. Brain 2014; 137: 232-241.
Kim JH, Kim S, Suh SI, et al. Interictal metabolic changes in episodic migraine: A voxel-based FDG-PET study. Cephalalgia 2010; 30: 53-61.
Sprenger T, Ruether KV, Boecker H, et al. Altered metabolism in frontal brain circuits in cluster headache. Cephalalgia 2007; 27: 1033-1042.
Aderjan D, Stankewitz A, May A,. Neuronal mechanisms during repetitive trigemino-nociceptive stimulation in migraine patients. Pain 2010; 151: 97-103.
Bashir A, Lipton RB, Ashina S, et al. Migraine and structural changes in the brain. Neurology 2013; 81: 1260-1268.
Dai Z, Zhong J, Xiao P, et al. Gray matter correlates of migraine and gender effect: A meta-analysis of voxel-based morphometry studies. Neuroscience 2015; 299: 88-96.
Schwedt TJ, Chiang C, Chong CD, et al. Functional MRI of migraine. Lancet Neurol 2015; 14: 81-91.
Maquet P, Dive D, Salmon E, et al. Reproducibility of cerebral glucose utilization measured by PET and the [18F]-2-fluoro-2-deoxy-d-glucose method in resting, healthy human subjects. Eur J Nucl Med 1990; 16: 267-273.
Schaefer S, Abercrombie H, Lindgren K,. Six-month test-retest reliability of MRI-defined PET measures of regional cerebral glucose metabolic rate in selected subcortical structures. Hum Brain Mapp 2000; 10: 1-9.
Bari AA, Pouratian N,. Brain imaging correlates of peripheral nerve stimulation. Surg Neurol Int 2012; 3 (Suppl 4): 260-268.
May A, Leone M, Boecker H, et al. Hypothalamic deep brain stimulation in positron emission tomography. J Neurosci 2006; 26: 3589-3593.
Ramsey RR, Ryan JL, Hershey AD, et al. Treatment adherence in patients with headache: A systematic review. Headache 2014; 54: 795-816.
